Rockwell Medical, Inc. (RMTI:NASDAQ) soared at $0.46, a gain of 22.6%. On Thu, Mar 24, 2022, RMTI:NASDAQ touched a New 2-Week Intraday High of $0.4. The stock got featured on our News Catalysts scanner on Wed, Mar 09, 2022 at 09:39 AM in the 'MISCELLANEOUS' category. From Thu, Mar 10, 2022, the stock recorded 40.00% Up Days and 54.55% Green Days
The stock spiked on Thu, Jan 13, 2022 at $0.65 with a volume of 63M+.
About Rockwell Medical, Inc. (RMTI:NASDAQ)
Rockwell Medical Inc is a biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease with its products and services for the treatment of iron deficiency, secondary hyperparathyroidism, and hemodialysis.
Top 10 Gainers:
- Clever Leaves Holdings Inc. (CLVR:NASDAQ), 143.04%
- Forge Global Holdings Inc. (FRGE:NYSE), 50.2%
- Fresh Vine Wine Inc. (VINE:NYSEMKT), 33.65%
- NextDecade Corporation (NEXT:NASDAQ), 32.22%
- Clarus Therapeutics Holdings Inc. (CRXT:NASDAQ), 25.95%
- Aileron Therapeutics, Inc. (ALRN:NASDAQ), 25.54%
- NexImmune Inc. (NEXI:NASDAQ), 23.12%
- Tilray, Inc. (TLRY:NASDAQ), 22.81%
- Rockwell Medical, Inc. (RMTI:NASDAQ), 22.63%
- Kidpik Corp. (PIK:NASDAQ), 22.54%